Comprehensive analysis of somatic mutations in small cell lung cancer exploring new therapeutic targets

Comprehensive analysis of somatic mutations in small cell lung cancer exploring new therapeutic targets - Comprehensive analysis of somatic mutations in small cell lung cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008950

Enrollment

580

Registered

2012-09-20

Start date

2012-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were performed thoracic surgery or biopsy at National Cancer Center Hospital East Histologically confirmed small cell lung cancer With sufficient amount of tumor tissues for the analyses

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Comprehensive somatic mutation analysis by whole exon next-generation sequencing Gene amplification analysis	—

Secondary

Measure	Time frame
Analysis of candidate somatic mutations in biopsy specimens Investigation of biological functions of candidate gene abnormalities using culture cell-system	—

Countries

Japan

Contacts

Public ContactShigeki Umemura

National Cancer Center Hospital East Division of Thoracic Oncology

sumemura@east.ncc.go.jp04-7133-1111

Outcome results